18th Annual HIV Conference – Home

This conference is designed to increase the knowledge and skills of HIV healthcare providers. Lectures and interactive case presentations will be supplemented by take-home materials. Five distinct tracks will allow participants to customize their conference experience to best meet their professional needs.

Jointly Sponsored By
USF Health
In Partnership With
Southeast Region STD/HIV Prevention Training Center
Southeast Region STD/HIV
Prevention Training Center
Southeastern National Tuberculosis Center

Keynote - Friday, May 1, 2009
Emerging Therapeutics

Marilyn Volker Jeff Nadler, M.D., F.A.C.P., is the Acting Director of the Therapeutics Research Program in the Division of Acquired Immunodeficiency Syndrome (DAIDS), at the National Institute of Allergy and Infectious Diseases (NIAID), with the National Institutes of Health (NIH). He is also currently a Professor of Medicine at George Washington University in Washington, DC. Previously, Dr. Nadler was a Professor of Medicine and Public Health, and Director of Clinical Research in Infectious Diseases at the University of South Florida in Tampa, FL. Dr. Nadler is a Fellow of the Infectious Diseases Society of America as well as a member of the HIV Medicine Association. He is a graduate of the New York Medical College and is affiliated with the Internal Medicine Department of the New York Medical College Metropolitan Hospital. With over one hundred publications to date, and having conducted extensive lectures on AIDS and related topics, Dr. Nadler is considered a noted authority in the field of HIV medicine. (Click here for details)


The University of South Florida (USF) works closely with the the University of Puerto Rico, University of Florida, the University of Miami, Florida A & M University, and the University of the Virgin Islands to develop AETC programs. A network of training partners provide faculty and clinical training sites throughout the region.Major funding for the AETC is provided by the U.S. Public Health Service's Health Resources and Services Administration (HRSA) DHHS-HAB Grant No. 6 H4AHA00049.